Moreover, activated ErbB3 has been observed in primary melanocytic lesions and this suggests that activation of NRG1/ErbB3 signaling may contribute to the progression of melanoma from benign nevi to metastatic malignancies. The gene discussed is ERBB3; the disease is melanoma.